Distinct inflammatory mechanisms mediate early versus late colitis in mice

Gastroenterology

Volumn 122, Issue 1, 2002, Pages 94-105

  Spencer, David M ^a   Veldman, Geertruida M ^a   Banerjee, Subhashis ^a   Willis, Joseph ^b   Levine, Alan D ^a,b,c  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PFIZER INC   (United States)

^c BASF Bioresearch Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 4;

ANIMAL CELL; ARTICLE; COLITIS; DIARRHEA; DISEASE SEVERITY; LAMINA PROPRIA; MONONUCLEAR CELL; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

EID: 0036142235     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2002.30308     Document Type: Article

References (46)

1. Inflammatory bowel disease: Etiology and pathogenesis
2. Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting
3. Induction of colitis in IL2-deficient-mice: The role of thymic and peripheral dysregulation in the generation of autoreactive T cells
4. Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity
5. Antibodies to interleukin 12 abrogate established experimental colitis in mice
6. Effect of IL-12 and antibodies to IL-12 on established granulomatous colitis in mice
7. Differential susceptibility of inbred mouse strains to dextran sulfate sodium-induced colitis
8. Interleukin 7 transgenic mice develop chronic colitis with decreased interleukin 7 protein accumulation in the colonic mucosa
9. Gi2 alpha protein deficiency: A model of inflammatory bowel disease
10. Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor
11. Interleukin-10-deficient mice develop chronic enterocolitis
12. T helper cell 1-type CD4+ T cells, but not B cells, mediate colitis in interleukin 10-deficient mice
13. 10 thymocytes in vivo
14. Pathogen induced Th1 phenotype development in CD4- alpha-beta-TCR transgenic T cells is macrophage dependent
15. Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor
16. Type 1 T-helper cell predominance and interleukin-12 expression in the gut of patients with Crohn's disease
17. Interleukin 12 is expressed and actively released by Crohn's disease intestinal lamina propria mononuclear cells
18. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells
19. Helicobacter hepaticus triggers colitis in specific-pathogen-free interleukin-10 (IL-10)-deficient mice through an IL-12- and gamma interferon-dependent mechanism
20. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice
21. IL-12, but not IFN-gamma, plays a major role in sustaining the chronic phase of colitis in IL-10-deficient mice
22. Anti-IL-12 therapy in IL-10-deficient mice prevents the onset of colitis and reverses early diseases, but is ineffective in late disease
23. T cell-mediated pathology in two models of experimental colitis depends predominantly on the interleukin 12/Signal transducer and activator of transcription (Stat)-4 pathway, but is not conditional on interferon gamma expression by T cells
24. Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells
25. + T cells and accompanied by overproduction of IL-12 IFN-γ, and TNF-α
26. IL-2-deficient mice raised under germfree conditions develop delayed mild focal intestinal inflammation
27. Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) Th1-like responses
28. Induction and prevention of colonic inflammation in IL-2-deficient mice
29. T-cell subsets (Th1 versus Th2)
30. Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells
31. Chronic colitis in IL-10-/- mice: Insufficient counter regulation of a Th1 response
32. IL-12 inhibits the production of IL-4 and IL-10 in allergen-specific human CD4+ T lymphocytes
33. Differential roles for IL-12 in the maintenance of immune responses in infectious versus autoimmune disease
34. Endogenous IL-12 is required for induction and expression of experimental autoimmune uveitis
35. Dual role of IL-12 in early and late stages of murine collagen type II arthritis
36. Parasite-induced IL-12 stimulates early IFN-γ synthesis and resistance during acute infection with Toxoplasma gondii
37. Cytokine production and surface marker expression in acute and stable multiple sclerosis: Altered IL-12 production and augmented signaling lymphocytic activation molecule (SLAM)-expressing lymphocytes in acute multiple sclerosis
38. Endogenous IL-12 is required for control of Th2 cytokine responses capable of exacerbating leishmaniasis in normally resistant mice
39. Studies with IL-10-/- mice: An overview
40. Bioactive IL-18 expression is up-regulated in Crohn's disease
41. IL-18, a novel immunoregulatory cytokine, is up-regulated in Crohn's disease: Expression and localization in intestinal mucosal cells
42. Immunoregulatory properties of IL-13: Its potential role in atopic disease
43. Characterization of cytokine expression in the rectal mucosa of ulcerative colitis: Correlation with disease activity
44. Colonic expression and synthesis of interleukin 13 and interleukin 15 in inflammatory bowel disease
45. IL-10 and the dangers of immune polarization: Excessive type 1 and type 2 cytokine responses induce distinct forms of lethal immunopathology in murine schistosomiasis
46. Prolonged duration of response to Infliximab in early pediatric Crohn's disease